CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
This Quarter Return
+34.07%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$104M
AUM Growth
+$104M
(+21%)
Cap. Flow
+$6.1M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
90.98%
Holding
48
New
9
Increased
23
Reduced
3
Closed
8
Top Buys
| 1 |
MTEM
Molecular Templates, Inc.
MTEM
|
$6.56M |
| 2 |
SCYNEXIS
SCYX
|
$3.29M |
| 3 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$942K |
| 4 |
Calumet Specialty Products
CLMT
|
$381K |
| 5 |
Cardlytics
CDLX
|
$352K |
Top Sells
| 1 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
$4.16M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$1.94M |
| 3 |
Credit Acceptance
CACC
|
$238K |
| 4 |
Expedia Group
EXPE
|
$237K |
| 5 |
Liberty Media Series C
FWONK
|
$224K |
Sector Composition
| 1 | Healthcare | 73.43% |
| 2 | Financials | 1.71% |
| 3 | Consumer Discretionary | 1.29% |
| 4 | Communication Services | 1.15% |
| 5 | Industrials | 0.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTEM
1
DELISTED
Molecular Templates, Inc.
MTEM
| $29.3M | 28.23% | 2,092,991 +468,750 | +29% | +$6.56M |
|
|
SBBP
2
DELISTED
Strongbridge Biopharma plc.
SBBP
| $13.8M | 13.33% | 6,612,065 | – | – |
|
|
STSA
3
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $13M | 12.51% | 659,252 -211,568 | -24% | -$4.16M |
|
|
ABDC
4
DELISTED
Alcentra Capital Corp
ABDC
| $9.1M | 8.77% | 1,005,000 +5,000 | +0.5% | +$45.2K |
|
|
5
SCYNEXIS
SCYX
$34.9M
| $7.22M | 6.97% | 7,936,111 +3,611,111 | +83% | +$3.29M |
|
|
GARS
6
DELISTED
Garrison Capital Inc.
GARS
| $7.12M | 6.87% | 1,223,096 | – | – |
|
7
KALA BIO
KALA
$78.8M
| $5.47M | 5.28% | 1,483,343 | – | – |
|
8
SPDR S&P 500 ETF Trust
SPY
$658B
| $4.51M | 4.35% | 14,010 | – | – |
|
|
VIRX
9
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.75M | 2.65% | 8,134,926 +2,789,100 | +52% | +$942K |
|
10
MEI Pharma
MEIP
$160M
| $2.1M | 2.02% | 845,560 | – | – |
|
|
EIGR
11
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $925K | 0.89% | 62,096 +81 | +0.1% | +$1.21K |
|
12
FS KKR Capital
FSK
$5.11B
| $684K | 0.66% | 111,653 +31,372 | +39% | +$192K |
|
|
13
Calumet Specialty Products
CLMT
$1.41B
| $621K | 0.6% | 170,149 +104,460 | +159% | +$381K |
|
|
CTIC
14
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $514K | 0.5% | 325,610 +425 | +0.1% | +$671 |
|
|
15
Cardlytics
CDLX
$54.3M
| $352K | 0.34% | +5,594 | New | +$352K |
|
16
Assembly Biosciences
ASMB
$190M
| $340K | 0.33% | +16,615 | New | +$340K |
|
|
ARQL
17
DELISTED
Arqule Inc
ARQL
| $310K | 0.3% | +15,522 | New | +$310K |
|
18
Charter Communications
CHTR
$36.3B
| $309K | 0.3% | 638 +3 | +0.5% | +$1.45K |
|
19
Kura Oncology
KURA
$686M
| $307K | 0.3% | 22,295 -9,272 | -29% | -$128K |
|
20
TransDigm Group
TDG
$78.8B
| $290K | 0.28% | 518 +2 | +0.4% | +$1.12K |
|
21
Mastercard
MA
$538B
| $286K | 0.28% | 959 +3 | +0.3% | +$895 |
|
22
Mercado Libre
MELI
$125B
| $285K | 0.27% | 498 +2 | +0.4% | +$1.15K |
|
23
Moody's
MCO
$91.4B
| $280K | 0.27% | 1,179 +4 | +0.3% | +$950 |
|
24
American Tower
AMT
$95.5B
| $279K | 0.27% | 1,214 +4 | +0.3% | +$919 |
|
25
Visa
V
$683B
| $276K | 0.27% | 1,470 +5 | +0.3% | +$939 |
|